BNP Paribas Exane cut shares of Nutrien (NYSE:NTR – Free Report) from an outperform rating to a neutral rating in a report released on Monday, MarketBeat reports.
Several other research analysts have also commented on the company. Wells Fargo & Company lifted their price target on Nutrien from $64.00 to $77.00 and gave the stock an “equal weight” rating in a report on Friday. Barclays lifted their target price on shares of Nutrien from $64.00 to $70.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 18th. Bank of America increased their price target on shares of Nutrien from $64.00 to $71.00 and gave the company a “neutral” rating in a research note on Friday. Oppenheimer restated an “outperform” rating on shares of Nutrien in a report on Tuesday, January 27th. Finally, Zacks Research upgraded Nutrien from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 27th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $71.17.
Check Out Our Latest Stock Analysis on NTR
Nutrien Trading Up 1.0%
Nutrien (NYSE:NTR – Get Free Report) last posted its quarterly earnings results on Wednesday, February 18th. The company reported $0.83 EPS for the quarter, missing the consensus estimate of $0.87 by ($0.04). The company had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.41%. Nutrien’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.31 EPS. Analysts predict that Nutrien will post 3.72 EPS for the current fiscal year.
Nutrien Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be given a $0.55 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This is a positive change from Nutrien’s previous quarterly dividend of $0.55. This represents a $2.20 dividend on an annualized basis and a yield of 3.1%. Nutrien’s dividend payout ratio is presently 46.78%.
Institutional Investors Weigh In On Nutrien
A number of institutional investors have recently modified their holdings of NTR. Compound Planning Inc. lifted its stake in Nutrien by 6.9% during the 4th quarter. Compound Planning Inc. now owns 5,371 shares of the company’s stock worth $332,000 after acquiring an additional 348 shares in the last quarter. Invesco Ltd. lifted its position in shares of Nutrien by 3.5% during the fourth quarter. Invesco Ltd. now owns 1,415,304 shares of the company’s stock worth $87,353,000 after purchasing an additional 47,798 shares in the last quarter. Alberta Investment Management Corp boosted its stake in shares of Nutrien by 13.0% in the fourth quarter. Alberta Investment Management Corp now owns 687,200 shares of the company’s stock valued at $42,418,000 after purchasing an additional 78,900 shares during the period. Mercer Global Advisors Inc. ADV boosted its stake in shares of Nutrien by 10.8% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 6,415 shares of the company’s stock valued at $396,000 after purchasing an additional 623 shares during the period. Finally, Mackenzie Financial Corp grew its holdings in shares of Nutrien by 4.4% in the fourth quarter. Mackenzie Financial Corp now owns 7,219,733 shares of the company’s stock valued at $450,310,000 after purchasing an additional 305,458 shares in the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.
More Nutrien News
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Several firms raised price targets on NTR (new targets include $85, $78, $77 and $74), signaling upward revisions to analyst outlooks that can support buying interest. Price Target $85 Price Target $78 Price Target $77 Price Target $74
- Positive Sentiment: Analysis highlights attractive valuation after Nutrien’s strong results, dividend increase and ongoing buybacks — factors that support shareholder returns and can justify a higher multiple. Valuation & Dividend/Buybacks
- Neutral Sentiment: A Zacks piece examines whether value investors should buy NTR, focusing on earnings-estimate trends and the Zacks Rank methodology — useful context but not an immediate catalyst. Zacks Analysis
- Negative Sentiment: BNP Paribas Exane downgraded Nutrien from “outperform” to “neutral,” citing rising pressure on nitrogen prices — a direct earnings risk for Nutrien’s fertilizer segment and a likely headwind for the stock. BNP Paribas Downgrade
- Negative Sentiment: Market summaries (e.g., Finviz) echoed the downgrade note, increasing visibility of the bearish analyst stance and potentially amplifying short-term selling pressure. Finviz Summary
Nutrien Company Profile
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
See Also
- Five stocks we like better than Nutrien
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
